Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, New York University Fertility Center, New York, New York, USA.
Fertil Steril. 2011 Mar 1;95(3):1178-81. doi: 10.1016/j.fertnstert.2010.09.053. Epub 2010 Nov 3.
In this case-control study of euthyroid first-cycle IVF patients ≥ 38 years old with singleton baby, miscarriage, biochemical pregnancy, and no pregnancy outcomes from 2005-2008, we assayed frozen serum for autoimmune thyroid disease (AITD) and thyroid function at cycle start, trigger, and 4 and 5 weeks' gestation. AITD prevalence in older infertile women was similar across clinical outcomes, and although AITD was associated with a higher baseline TSH, TSH remained within acceptable ranges, suggesting that T(4) supplementation may not affect maternal outcomes in older euthyroid AITD patients through 5 weeks gestation.
在这项对 2005 年至 2008 年间年龄≥38 岁的甲状腺功能正常的首周期 IVF 患者(单胎婴儿、流产、生化妊娠和无妊娠结局)的病例对照研究中,我们在周期开始、扳机和 4 周及 5 周妊娠时检测了冷冻血清中的自身免疫性甲状腺疾病(AITD)和甲状腺功能。在不同临床结局中,高龄不孕女性的 AITD 患病率相似,尽管 AITD 与较高的基础 TSH 相关,但 TSH 仍处于可接受范围内,这表明在 5 周妊娠前,T4 补充可能不会影响高龄甲状腺功能正常的 AITD 患者的母婴结局。